Savior LLC’s Novartis NVS Stock Holding History

Savior LLC’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-90	Closed	-$7K	–	200
2021 Q3	$7K	Sell	90 -263	-75%	-$23.7K	0.01%	118
2021 Q2	$32K	Hold	353	–	–	0.03%	216
2021 Q1	$30K	Hold	353	–	–	0.03%	225
2020 Q4	$33K	Hold	353	–	–	0.03%	202
2020 Q3	$31K	Hold	353	–	–	0.04%	186
2020 Q2	$31K	Sell	353 -31	-8%	-$2.68K	0.04%	170
2020 Q1	$32K	Sell	384 -80	-17%	-$7.14K	0.04%	151
2019 Q4	$44K	Buy	+464	New	+$41.6K	0.06%	169

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Savior LLC's NVS Position: Q4 2021 in Review

Savior LLC sold out of Novartis (NVS) in Q4 2021, closing a stake of 90 shares — an estimated $7K sold.

Savior LLC first reported a position in NVS in Q4 2019 and held it in 8 quarters. The position peaked at $44K in Q4 2019. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

Savior LLC reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
Savior LLC sold 90 Novartis shares in Q4 2021, an estimated $7K.
Savior LLC first reported a position in Novartis in Q4 2019 and held it in 8 quarters.
Savior LLC's Novartis position peaked at $44K in Q4 2019.
1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Savior LLC's 13F filing for Q4 2021, filed 3 Feb 2022.